First Anti-TNF Biologic Therapy To Treat 1 Million Patients Worldwide

First Anti-TNF Biologic Therapy To Treat 1 Million Patients Worldwide
Medical News Today - REMICADE is also approved in the EU for the treatment of moderate to severe plaque psoriasis in adults who failed to respond to, or have a contraindication to, or are intolerant of other systemic therapy including cyclosporine, methotrexate or PUVA